Publikace
- Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib2021 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC2017 | Lékařská fakulta v Plzni, 1. lékařská fakulta, Přírodovědecká fakulta
- Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC2016 | Lékařská fakulta v Plzni, Přírodovědecká fakulta
- Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib2016 | Lékařská fakulta v Plzni, Přírodovědecká fakulta
- Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate2024 | Lékařská fakulta v Plzni
- Exome Sequencing of Paired Colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction2023 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience2023 | Lékařská fakulta v Plzni
- Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection2022 | Lékařská fakulta v Plzni
- Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line2021 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Nežádoucí účinky a efekt imunoterapie2020 | Lékařská fakulta v Plzni
Loading network view...